Acetylcholine agonists and antagonists Flashcards
Function of ChAT enzyme
Synthesizes Ach from acetyl-CoA and choline in the nerve terminal
Enzyme that metabolizes Ach in the synaptic cleft and thereby terminates its action
Acetylcholinesterase (AchE)
Toxin that enters cholinergic nerve terminals and prevents the release of Ach, causing a neuromuscular blocking effect
Botulinum toxin
Presynaptic membrane protein required for the fusion of NT containing vesicles. Cleaved by botulinum toxin
SNAP - synaptosome associated protein
Presynaptic membrane protein that helps in vesicle transport and fusion at the plasma membrane. Cleaved by botulinum toxin.
VAMP - vesicle associated membrane protein
Therapeutic uses of botulinum toxin
Management of muscle dystonia and spasticity
Chronic pain and localized muscle spasms
Cosmetic use
Agent that enters presynaptic neuron to prevent packaging of Ach into vesicles
Vesamicol
Agent that prevents choline entry into presynaptic neuron, thereby limiting the production of Ach
Hemicholinium
Cholinesterase with a lower specificity for Ach compared to acetylcholinesterase. Found in blood plasma, liver, glia, and many other tissues. Main function is hydrolysis of ingested esters.
Butyrylcholinesterase (pseudocholinesterase)
Neuromuscular blocking agents, not including botulinum toxin
Atracurium
Cisatracurium
Pancuronium
Rocuronium
Vecuronium
Succinylcholine
Atracurium route of elimination
Plasma esterase
Cisatracurium route of elimination
Spontaneous chemical degradation
Pancuronium route of elimination
Renal excretion
Rocuronium route of elimination
Biliary and renal excretion
Vecuronium route of elimination
Biliary and renal excretion
Hepatic metabolism
Succinylcholine route of elimination
Plasma (butyryl) cholinesterase
Side effects of succinylcholine
Prolonged apnea
Hyperkalemia leading to MI
Postop myalgia
Malignant hyperthermia
Risk factor for prolonged apnea from succinylcholine
Genetic inheritance of atypical cholinesterase or deficiency of pseudocholinesterase –> results in slow metabolism
Risk factors for hyperkalemia side effect from succinylcholine
Unhealed muscle injury
Intra-abdominal infection
Paralysis/spinal cord injury
Child
Risk factor for malignant hyperthermia in succinylcholine use
Use with inhalation anesthetics
Muscarinic cholinergic receptor is what type of receptor?
GPCR
Nicotinic cholinergic receptor is what type of receptor?
Nicotinic
Result of M1 receptor stimulation
Gq receptor –> Increase IP3 and DAG cascade
Result of M2 receptor stimulation
Gi –> decrease cAMP synthesis
Result of M3 receptor stimulation
Gq –> increase IP3 and DAG cascade
Result of M4 receptor stimulation
Gi –> decrease cAMP synthesis
Result of M5 receptor stimulation
Gq –> increase IP3 and DAG cascade
Gq muscarinic receptors
M1, M3, and M5
Gi muscarinic receptors
M2 and M4
Result of nicotinic receptor stimulation
Na/K depolarizing current
Agent that selectively blocks muscarinic receptors
Atropine
Muscarinic receptor type primarily present in gastric glands, CNS, and autonomic ganglia. Mediates gastric acid secretion and relaxation of LES. Role in learning, memory, and motor functions.
M1
Muscarinic receptor type primarily located in heart and CNS. Mediates vagal bradycardia.
M2
Muscarinic receptor type primarily located in visceral smooth muscle, glands, vascular endothelium, iris, and ciliary muscles. Mediates visceral smooth muscle contraction, vasodilation, constriction of pupil, and contraction of ciliary muscle.
M3
Agents that can block nicotinic receptors
Tubocurarine
Hexamthonium
Agonists of Nm receptors
Ach
Carbachol (CCh)
Suxamethonium
Antagonists of Nm receptors
Tubocurarine
Atracurium
Agonists of Nn receptors
Ach
Carbachol (CCh)
Nicotine
Antagonists of Nn receptors
Trimethaptan
Hexamethonium
Affect of SA node hyperpolarization
Decrease in rate of diastolic depolarization, reduction in impulse generation –> bradycardia